search
Back to results

Extracorporeal Shock Wave Therapy for Dysmenorrhea

Primary Purpose

Primary Dysmenorrhea

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
shock wave therapy
dietary modification
Sponsored by
MTI University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Primary Dysmenorrhea

Eligibility Criteria

18 Years - 25 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. ages ranged between18 - 25 years old.
  2. body mass index (BMI) will not exceed 30kg/m2.
  3. females will be diagnosed by the physician as primary dysmenorrhea.

Exclusion Criteria:

  1. Secondary dysmenorrhea .
  2. Mental health problem such as depression and anxiety.
  3. Irregular periods

Sites / Locations

  • MTI

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

shock wave

dietary modification

Arm Description

shock wave for primary dysmenorrhea for study group along side to dietary modification

dietary modification for primary dysmenorrhea for control group

Outcomes

Primary Outcome Measures

numerical rating scale
Numeric rating scale will be 10 cm digital line with 0 (zero) representing feeling no pain and 10 representing feeling the worst pain, was used to assess the severity of the pain before and after treatment for all females in both groups (A&B). measurement will done twice first one at baseline(will be considered as pre treatment measure) and 2nd on e at 3rd menstrual cycle ( will be considered as post treatment measure)

Secondary Outcome Measures

prostaglandin
5cm plasma concentrations of prostaglandin F2α was taken from all females and was analyzed in the Laboratory index to determine the prostaglandin plasma level measurement will done twice before after the treatment program.

Full Information

First Posted
November 22, 2020
Last Updated
March 20, 2021
Sponsor
MTI University
Collaborators
Ghada ebrahim El Refaye -Faculty of Physical Therapy, Cairo University, Egypt, Sohier Mahmmoud El Koseiry- Faculty of Physical Therapy, Cairo University, Egypt
search

1. Study Identification

Unique Protocol Identification Number
NCT04662814
Brief Title
Extracorporeal Shock Wave Therapy for Dysmenorrhea
Official Title
the Efficacy of Extracorporeal Shock Wave Therapy for Primary Dysmenorrhea
Study Type
Interventional

2. Study Status

Record Verification Date
March 2021
Overall Recruitment Status
Completed
Study Start Date
September 12, 2020 (Actual)
Primary Completion Date
December 24, 2020 (Actual)
Study Completion Date
January 27, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
MTI University
Collaborators
Ghada ebrahim El Refaye -Faculty of Physical Therapy, Cairo University, Egypt, Sohier Mahmmoud El Koseiry- Faculty of Physical Therapy, Cairo University, Egypt

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
purpose of this study to investigate the effect of Extracorporeal shock wave therapy on pain and prostaglandin level in patient with primary dysmenorrhea
Detailed Description
This randomized controlled trial is to determine the effect of shock wave therapy in the treatment of primary dysmenorrhea. females are randomly assigned into 2 groups: group A SWT treatment plus dietary modification during PD (n=25) GROUP B:dietary modification only (n=25); Participants in group B will receive dietary modification for three successive months The numerical rating scale (NRS) and prostaglandin blood level will be recorded and evaluated before and after treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Primary Dysmenorrhea

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
group A: shockwave therapy and dietary modification group B: dietary modification
Masking
Participant
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
shock wave
Arm Type
Experimental
Arm Description
shock wave for primary dysmenorrhea for study group along side to dietary modification
Arm Title
dietary modification
Arm Type
Active Comparator
Arm Description
dietary modification for primary dysmenorrhea for control group
Intervention Type
Other
Intervention Name(s)
shock wave therapy
Intervention Description
Intervention group is by shock wave therapy. A radial shock wave device (EME, ITALY) was used. for 4 sessions (one session before the expected day of period and session per day for day1 , day 2 and day 3 of each menstrual cycle) for three successive periods.
Intervention Type
Other
Intervention Name(s)
dietary modification
Intervention Description
Participants will receive dietary modification for three consecutive months dietary modification will be low caffeine and high water and liquids intake and reduce the uptake of fast food, should be followed for 3 months
Primary Outcome Measure Information:
Title
numerical rating scale
Description
Numeric rating scale will be 10 cm digital line with 0 (zero) representing feeling no pain and 10 representing feeling the worst pain, was used to assess the severity of the pain before and after treatment for all females in both groups (A&B). measurement will done twice first one at baseline(will be considered as pre treatment measure) and 2nd on e at 3rd menstrual cycle ( will be considered as post treatment measure)
Time Frame
3 months
Secondary Outcome Measure Information:
Title
prostaglandin
Description
5cm plasma concentrations of prostaglandin F2α was taken from all females and was analyzed in the Laboratory index to determine the prostaglandin plasma level measurement will done twice before after the treatment program.
Time Frame
3months

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: ages ranged between18 - 25 years old. body mass index (BMI) will not exceed 30kg/m2. females will be diagnosed by the physician as primary dysmenorrhea. Exclusion Criteria: Secondary dysmenorrhea . Mental health problem such as depression and anxiety. Irregular periods
Facility Information:
Facility Name
MTI
City
Cairo
Country
Egypt

12. IPD Sharing Statement

Learn more about this trial

Extracorporeal Shock Wave Therapy for Dysmenorrhea

We'll reach out to this number within 24 hrs